The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Dermatological Research

• Publication date

  2003-03-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00403-003-0389-4PMID 12709818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MON-150, a versatile monoclonal antibody against involucrin: characterization and applications

  2004cited by this paper
• Effect of a lipid‐rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction

  2002cited by this paper
• Efficacy of corticosteroids in acute experimental irritant contact dermatitis?

  2001cited by this paper
• Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation.

  2000cited by this paper
• Association of TNFA gene polymorphism at position –308 with susceptibility to irritant contact dermatitis

  2000cited by this paper
• Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate.

  2000cited by this paper
• Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study

  1999cited by this paper
• Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents.

  1999cited by this paper
• Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis

  1999cited by this paper
• Cutaneous barrier repair and pathophysiology following barrier disruption in IL‐1 and TNF type I receptor deficient mice

  1999cited by this paper
• SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.

  1998cited by this paper
• Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin

  1997cited by this paper
• Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation

  1997cited by this paper
• Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.

  1997cited by this paper
• In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.

  1996cited by this paper
• Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.

  1996cited by this paper
• Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate

  1996cited by this paper
• In vivo cytokine profiles in allergic and irritant contact dermatitis

  1995cited by this paper
• Acute irritant dermatitis: effect of short-term topical corticoid treatment.

  1995cited by this paper
• Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms.

  1995cited by this paper
• Efficacy of topical corticosteroids on irritant skin reactions

  1995cited by this paper
• Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.

  1994cited by this paper
• Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro.

  1994cited by this paper
• Barrier function regulates epidermal lipid and DNA synthesis

  1993cited by this paper
• Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

  1992influential reference
• Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions

  1991cited by this paper
• Guidelines for transepidermal water loss (TEWL) measurement

  1990cited by this paper
• Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.

  1989cited by this paper
• Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring.

  1989cited by this paper
• Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.

  1989cited by this paper

• Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches

  2025cites this paper
• Unveiling the potential of xanthines, discovery of potential 7-benzyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione derivatives with antifibrotic activity for liver injury.

  2025cites this paper
• Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Clinical Aspects of Irritant Contact Dermatitis

  2020cites this paper
• Therapy of Allergic and Irritant Contact Dermatitis

  2020cites this paper
• Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors.

  2019cites this paper
• Allergic contact dermatitis

  2019cites this paper
• Nickel contact dermatitis in children.

  2015cites this paper
• Complications of Wound Healing

  2012cites this paper
• Therapy and Rehabilitation of Allergic and Irritant Contact Dermatitis

  2011cites this paper
• Phosphorylation Site PDE 1 PDE 2 PDE 3 PDE 4 PDE 5 PDE 6 PDE 7 PDE 8 PDE 9 PDE 10 PDE 11

  2009cites this paper
• Management of occupational dermatitis.

  2009cites this paper
• Alkylxanthines and Phosphodiesterase 4 Inhibitors for Allergic Diseases

  2009cites this paper
• ABCD of the phosphodiesterase family: interaction and differential activity in COPD

  2008cites this paper
• Anti-Irritants: Myth or Reality? An Overview

  2004cites this paper
• Treatment of irritant and allergic contact dermatitis

  2004cites this paper